Apoptosis induced by cationic liposome based on the mitochondrial signaling pathway in vitro
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Nanoplatforms for cancer theranostics · Anesthesia and Neurotoxicity Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (35)
Show source-provided references
1. Ma K, Mi CL, Cao XX, Wang TY (2021) Progress of cationic gene delivery reagents for non-viral vector. Appl Microbiol Biotechnol 105:52510.1007/s00253-020-11028-6 ↗
2. Zhi D, Bai Y, Yang J, Cui S, Zhao Y, Chen H, Zhang S (2018) A review on cationic lipids with different linkers for gene delivery. Adv Colloid Interface Sci 253:11710.1016/j.cis.2017.12.006 ↗
3. Butt MH, Zaman M, Ahmad A, Khan R, Mallhi TH, Hasan MM, Khan YH, Hafeez S et al (2022) Appraisal for the potential of viral and nonviral vectors in gene therapy: a review. Genes (Basel) 13(8):137010.3390/genes13081370 ↗
4. Grijalvo S, Puras G, Zarate J, Sainz-Ramos M, Qtaish NAL, Lopez T, Mashal M, Attia N et al (2019) Cationic niosomes as non-viral vehicles for nucleic acids: challenges and opportunities in gene delivery. Pharmaceutics 11(2):5010.3390/pharmaceutics11020050 ↗
5. Wang Y, Gao S, Ye WH, Yoon HS, Yang YY (2006) Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer. Nat Mater 5:79110.1038/nmat1737 ↗
6. Zhang C, Zhao Y, Zhang E, Jiang M, Zhi D, Chen H, Cui S, Zhen Y et al (2020) Co-delivery of paclitaxel and anti-VEGF siRNA by tripeptide lipid nanoparticle to enhance the anti-tumor activity for lung cancer therapy. Drug Deliv 27:139710.1080/10717544.2020.1827085 ↗
7. Ewert KK, Scodeller P, Simon-Gracia L, Steffes VM, Wonder EA, Teesalu T, Safinya CR (2021) Cationic liposomes as vectors for nucleic acid and hydrophobic drug therapeutics. Pharmaceutics 13(9):136510.3390/pharmaceutics13091365 ↗
8. Zhi D, Zhang S, Wang B, Zhao Y, Yang B, Yu S (2010) Transfection efficiency of cationic lipids with different hydrophobic domains in gene delivery. Bioconjug Chem 21:56310.1021/bc900393r ↗
9. Ma W, Fu X, Zhao T, Qi Y, Zhang S, Zhao Y (2024) Development and applications of lipid hydrophilic headgroups for nucleic acid therapy. Biotechnol Adv 74:10839510.1016/j.biotechadv.2024.108395 ↗
10. Liu C, Zhang L, Zhu W, Guo R, Sun H, Chen X, Deng N (2020) Barriers and strategies of cationic liposomes for cancer gene therapy. Mol Ther Methods Clin Dev 18:75110.1016/j.omtm.2020.07.015 ↗
11. Park H, Otte A, Park K (2022) Evolution of drug delivery systems: From 1950 to 2020 and beyond. J Control Release 342:5310.1016/j.jconrel.2021.12.030 ↗
12. Knudsen KB, Northeved H, Kumar PE, Permin A, Gjetting T, Andresen TL, Larsen S, Wegener KM et al (2015) In vivo toxicity of cationic micelles and liposomes. Nanomedicine 11:46710.1016/j.nano.2014.08.004 ↗
13. Dokka S, Toledo D, Shi X, Castranova V, Rojanasakul Y (2000) Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes. Pharm Res 17:52110.1023/A:1007504613351 ↗
14. Wu Y, Xiong Y, Wang L, Zhou Q, Li L, Levkin PA, Davidson G, Gao L et al (2020) Development of new self-assembled cationic amino liposomes for efficient gene delivery. Biomater Sci 8:302110.1039/D0BM00331J ↗
15. Wu Y, Li L, Chen Q, Su Y, Levkin PA, Davidson G (2016) Single-tailed lipidoids enhance the transfection activity of their double-tailed counterparts. ACS Comb Sci 18:4310.1021/acscombsci.5b00117 ↗
16. Zhao Y, Zhang S, Zhang Y, Cui S, Chen H, Zhi D, Zhen Y, Zhang S et al (2015) Tri-peptide cationic lipids for gene delivery. J Mater Chem B 3:11910.1039/C4TB01312C ↗
17. Mandal S, Mallik S, Bhoumick A, Bhattacharya A, Sen P (2024) Synthesis of amino acid-based cationic lipids and study of the role of the cationic head group for enhanced drug and nucleic acid delivery. ChemBioChem 25(6):e20230083410.1002/cbic.202300834 ↗
18. Ponti F, Campolungo M, Melchiori C, Bono N, Candiani G (2021) Cationic lipids for gene delivery: many players, one goal. Chem Phys Lipids 235:10503210.1016/j.chemphyslip.2020.105032 ↗
19. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:64610.1016/j.cell.2011.02.013 ↗
20. Castaño D, Rattanasopa C, Monteiro-Cardoso VF, Corlianò M, Liu Y, Zhong S, Rusu M, Liehn EA et al (2020) Lipid efflux mechanisms, relation to disease and potential therapeutic aspects. Adv Drug Deliv Rev 159:5410.1016/j.addr.2020.04.013 ↗
21. Poltorak A (2022) Cell death: all roads lead to mitochondria. Curr Biol 32:R89110.1016/j.cub.2022.07.025 ↗
22. Xiao D, He H, Huang W, Oo TL, Wang A, He LF (2018) Analysis of mitochondrial markers of programmed cell death. Methods Mol Biol 1743:6510.1007/978-1-4939-7668-3_6 ↗
23. Jomova K, Raptova R, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, Valko M (2023) Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging. Arch Toxicol 97:249910.1007/s00204-023-03562-9 ↗
24. Nakamura H, Takada K (2021) Reactive oxygen species in cancer: current findings and future directions. Cancer Sci 112:394510.1111/cas.15068 ↗
25. Weinberg F, Ramnath N, Nagrath D (2019) Reactive oxygen species in the tumor microenvironment: an overview. Cancers (Basel) 11(8):119110.3390/cancers11081191 ↗
26. Yang B, Chen Y, Shi J (2019) Reactive oxygen species (ROS)-based nanomedicine. Chem Rev 119:488110.1021/acs.chemrev.8b00626 ↗
27. Kalpage HA, Wan J, Morse PT, Zurek MP, Turner AA, Khobeir A, Yazdi N, Hakim L et al (2020) Cytochrome c phosphorylation: Control of mitochondrial electron transport chain flux and apoptosis. Int J Biochem Cell Biol 121:10570410.1016/j.biocel.2020.105704 ↗
28. Soderquist RS, Crawford L, Liu E, Lu M, Agarwal A, Anderson GR, Lin KH, Winter PS et al (2018) Systematic mapping of BCL-2 gene dependencies in cancer reveals molecular determinants of BH3 mimetic sensitivity. Nat Commun 9:351310.1038/s41467-018-05815-z ↗
29. Asadi M, Taghizadeh S, Kaviani E, Vakili O, Taheri-Anganeh M, Tahamtan M, Savardashtaki A (2022) Caspase-3: Structure, function, and biotechnological aspects. Biotechnol Appl Biochem 69:163310.1002/bab.2233 ↗
30. Popgeorgiev N, Gil C, Berthenet K, Bertolin G, Ichim G (2024) Shedding light on mitochondrial outer-membrane permeabilization and membrane potential: state of the art methods and biosensors. Semin Cell Dev Biol 156:5810.1016/j.semcdb.2023.07.003 ↗
31. Zorova LD, Popkov VA, Plotnikov EY, Silachev DN, Pevzner IB, Jankauskas SS, Babenko VA, Zorov SD et al (2018) Mitochondrial membrane potential. Anal Biochem 552:5010.1016/j.ab.2017.07.009 ↗
32. Bock FJ, Tait SWG (2020) Mitochondria as multifaceted regulators of cell death. Nat Rev Mol Cell Biol 21:8510.1038/s41580-019-0173-8 ↗
33. Kalpage HA, Bazylianska V, Recanati MA, Fite A, Liu J, Wan J, Mantena N, Malek MH et al (2019) Tissue-specific regulation of cytochrome c by post-translational modifications: respiration, the mitochondrial membrane potential, ROS, and apoptosis. FASEB J 33:154010.1096/fj.201801417R ↗
34. Santucci R, Sinibaldi F, Cozza P, Polticelli F, Fiorucci L (2019) Cytochrome c: an extreme multifunctional protein with a key role in cell fate. Int J Biol Macromol 136:123710.1016/j.ijbiomac.2019.06.180 ↗
35. Imran M, Aslam Gondal T, Atif M, Shahbaz M, Batool Qaisarani T, Hanif Mughal M, Salehi B, Martorell M et al (2020) Apigenin as an anticancer agent. Phytother Res 34:181210.1002/ptr.6647 ↗